• TC TECH Sweden AB (publ) - rights issue 2018

    Arctic Securities is acting as financial advisor in relation to the rights issue in TC TECH Sweden AB (publ). TC TECH Sweden AB (publ) is referred to as “TC TECH” or “the Company”. Shareholders have pre-emptive rights to subscribe for shares. Six (6) existing shares held on the record date of November 23 2018, entitles to one (1) new share. Subscription price of SEK 14 SEK per share. An overallotment issue of SEK 10m is conditioned on a fully subscribed rights issue. The subscription period runs 28 November – 12 December 2018. The rights issue is fully secured through subscription- and guarantee undertakings. A Swedish prospectus and subscription note will be available before the subscription period on TC TECH’s website, www.tctech.se and Arctic Securities website.

    Read more
  • Enorama Pharma AB (publ) - Rights issue 2018

    Arctic Securities is acting as financial advisor in relation to the rights issue in Enorama Pharma AB (publ) of SEK 25m. Enorama Pharma AB (publ) is referred to as “Enorama Pharma” or “the Company”.Shareholders have pre-emptive rights to subscribe for shares. Ten (10) existing shares held on the record date of October 30, 2018, entitles to one (1) new share. Subscription price of SEK 52 SEK per share. The subscription period runs 1 November – 16 November, 2018. The rights issue is secured up to 85 percent through subscription- and guarantee undertakings. A Swedish memorandum and subscription note will be available before the subscription period on Enorama Pharma’s website, www.enorama.se and Arctic Securities website.

    Read more
  • Idogen AB (publ) - Rights issue 2018

    Arctic Securities is acting as financial advisor in relation to the rights issue in Idogen AB (publ) of SEK 61m. Idogen AB (publ) is referred to as “Idogen” or “the Company”. Shareholders have pre-emptive right to subscribe for shares. Three (3) existing shares held on the record date of November 14 2018, entitles to five (5) new shares. Subscription price of SEK 1.75 per new share. The subscription period runs 20 November – 5 December 2018. The rights issue is secured up to 80 percent through subscription- and guarantee undertakings. A Swedish prospectus and subscription note will be available before the subscription period on Idogen’s website, www.idogen.com and Arctic Securities website.

    Read more